Breast Cancer: From Bench to Personalized Medicine

Breast Cancer: From Bench to Personalized Medicine

R 8 401.00

Takealot ยท checked 5 days ago

View at Takealot
Average
R 8 839.00
Lowest seen
R 8 401.00
Highest seen
R 8 839.00
Last change
-R 438.00
First indexed
24 Sep 2026
Retailer
Takealot

Description

Chapter 1_Epidemiology and risk factors of breast cancer. - Chapter 2_Histopathological characteristics: Breast cancer sub-types depending on receptor status, Clinical and pathological staging of breast cancer. - Chapter 3_Relationship of Breast Cancer with other Hormone Sensitive Cancers. - Chapter 4_Cancer care and psychosocial needs. - Chapter 5_BRCA1, BRCA2 associated breast carcinogenesis (screening, diagnosis, prevention and limitations). - Chapter 6_Early-stage progression of breast cancer (Molecular classification, Role of high and low penetrance genes in breast cancer). - Chapter 6_Noninvasive biomarkers for early detection of breast cancer / Mutational spectrum of breast cancer. - Chapter 7_Epigenetical Involvement in Breast Cancer / Epistatic Gene Pairs and Breast Cancer Prognosis. - Chapter 8_Role of Fibrolytic Mechanisms in Breast Cancer Diagnosis, Prognosis and Treatment. - Chapter 9_microRNAs and non-coding RNAs as Gene Regulators and Potential Therapeutic Agents. - Chapter 10_Circulating tumour cells. - Chapter 11_Angiogenesis and PARP Inhibitors (drugs) in Breast Cancer leading towards personalized treatment with better survival rates, Neoadjuvant, metastatic and combination settings, relationship to hormone receptor tumor types. - Chapter 12_Therapeutic options in BRCA1 linked breast cancer and systemic approaches . - Chapter 13_Biomarkers for predicting drug response and disease severity, pros and cons of currently available drug regimens considering pharmacogenomics approach. - Chapter 14_Transcriptional control leading to clinical outcomes in breast cancer cases. - Chapter 15_Utility of personalized medicine in the treatment of different subtypes of breast cancer. - Chapter 16_Association of molecular progression of breast cancer and personalized medicine in terms of clinical trials. - Chapter 17_Chemo-tolerance of breast cancer and its management by personalized medicine. - Chapter 18_Advances in breast cancer surgical pathology. - Chapter 19_Modern radiation therapy techniques and their toxicities for breast cancer. - Chapter 20_Nanomedicine and breast cancer treatment. - Chapter 21_Emerging paradigm of breast cancer resistance and treatment

โ€‹

Similar products